Analysis of IDH1 and IDH2 mutations in Japanese glioma patients

Cancer Science

Volumn 100, Issue 10, 2009, Pages 1996-1998

  Sonoda, Yukihiko ^a   Kumabe, Toshihiro ^a   Nakamura, Taigen ^a   Saito, Ryuta ^a   Kanamori, Masayuki ^a   Yamashita, Yoji ^a   Suzuki, Hiroyoshi ^b   Tominaga, Teiji ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SENDAI CITY MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE ISOENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GROWTH; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; WILD TYPE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BRAIN NEOPLASMS; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GLIOMA; HUMANS; ISOCITRATE DEHYDROGENASE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 70349594347     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01270.x     Document Type: Article

References (15)

1. Kleihues P, Cavenee WK, Kleihues P, Cavenee WK. Pathology and genetics of tumours of the nervous system. World Health Organization Classification of Tumours 2000, In, eds, Lyon, IARC
2. Ohgaki H, Dessen P, Jourde B. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004, 64:6892-9.
3. Parsons DW, Jones S, Zhang X. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-12.
4. Koshland DE Jr, Walsh K, LaPorte DC. Sensitivity of metabolic fluxes to covalent control. Curr Top Cell Regul 1985, 27:13-22.
5. Xu X, Zhao J, Xu Z. Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity. J Biol Chem 2004, 279:33 946-57.
6. Yan H, Parsons DW, Jin G. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009, 360:765-73.
7. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 2008, 116:597-602.
8. Ichimura K, Pearson DM, Kocialkowski S. IDH1 mutations are present in the majority of common adult gliomas but are rare in primary glioblastomas. Neuro Oncol 2009, doi 10.1215/15228517-2009-025
9. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 2009, 174:1149-53.
10. Bleeker FE, Lamba S, Leenstra S. IDH1 mutations at residue p.R132 (IDH1) (R132) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 2009, 30:7-11.
11. Holdhoff M, Parsons DW, Diaz LA Jr. Mutations of IDH1 and IDH2 are not detected in brain metastases of colorectal cancer. J Neurooncol 2009, doi 10.1007/s11060-009-9855-y
12. Kang MR, Kim MS, Oh JE. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer 2009, 125:353-5.
13. Scherer HJ. Cerebral astrocytomas and their derivatives. Am J Cancer 1940, 40:159-98.
14. Sonoda Y, Kumabe T, Watanabe M. Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurol 2009, doi 10.1007/s00701-009-0387-1
15. Zhao S, Lin Y, Xu W. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 2009, 324:261-5.